In-licensing is perhaps the fastest growing component for augmentation of R&D pipelines in the pharmaceutical industry today. In-licensing opportunities can span the entire range of drug discovery, development, and commercialization and include proprietary research technologies designed to explore ...
The threat of lower profit margins and decreasing revenue streams
is creating intense pressure for many pharmaceutical and
biopharmaceutical companies. Patent expirations loom for major
brands, average drug development costs continue to rise, while research
and development productivity is ...
This paper provides practical guidance on the steps to take to successfully execute a licensing agreement.
Immuno-oncology (IO) is a fast-growing field at the frontier of cancer therapy. Data from ClinicalTrials.gov indicates a fiercely competitive landscape with over 47,000 oncology trials globally and nearly 1,000 IO studies. Many IO studies are precision medicine driven clinical trials that target ...